(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
2 bright planets light up April evenings — here's where and when to look - 2Vote In favor of Your Favored Web-based Visual depiction Administration
- 3Munich Security Conference chief defends inviting AfD lawmakers
- 4Feeling wonder every day improves our health. Here’s how to do it.
- 5Abbott issues US device correction for some glucose monitors over faulty readings risk
- This is Countdown, CNN’s newsletter covering NASA’s first time sending humans to deep space in over 50 years
- Hilary Duff announces new album ‘Luck… or Something,’ her first in over 10 years: ‘Excited is the largest understatement’
- Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
- Day to day Temporary Positions That Compensate Fairly in the US
- ‘Democratizing space’ is more than just adding new players – it comes with questions around sustainability and sovereignty
- Winter storm warnings issued across Northeast as up to 9 inches of snow forecast; deadly atmospheric river in California snarls travel
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- Ukrainian Army Converts E38 BMW 7-Series Into Multiple Rocket Launch Platform
- Explainer-What has happened to the damaged spacecraft at China's space station?
